Helsinn Healthcare SA
Helsinn Healthcare SA
Explore linked clinical trials.2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC) | Nausea, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting | Recruiting | Phase 2 | 2026-09-29 | NCT06904235 | |
| NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd | Patients With HER2-low Advanced Breast Cancer Treated With T-DXd; Patients With HER2-positive Advanced Breast Cancer Treated With T-DXd | Enrolling by invitation | Not stated | 2026-01-08 | NCT07132749 |